Autonomic Nervous System Neoplasm

Observed

→ investigated in trials for

Doxorubicinsmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Everolimussmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Axitinibsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cabozantinibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Filgrastimother

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ifosfamidesmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lutetium (177lu) Oxodotreotideother

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nivolumabmonoclonal antibody

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sunitinibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vorinostatsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Belzutifansmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bevacizumabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Capecitabinesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cisplatinsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cixutumumabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cyclophosphamidesmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dovitinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fludarabinesmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ipilimumabmonoclonal antibody

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Irinotecansmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lenvatinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Linsitinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Olaparibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pazopanibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pembrolizumabmonoclonal antibody

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tamoxifensmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Temsirolimussmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tipifarnibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vandetanibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vatalanibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Veliparibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

Autonomic Nervous System Neoplasm studied in …STUDIED_INderived10 of 148show all (up to 200)
→ studied in	NCT00004847Phase 1 · recruiting Diagnosis of Pheochromocytoma · condition mapped ALIAS · 148 trials mapped (50 active)	—	—	Adrenal Gland Pheochromocytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07743138Phase 2 · not yet recruiting STOMP OUT: A Phase 2 Study To Evaluate The Effects Of Ivonescimab In Patients With Unresectable/Metastatic Adrenocortical Carcinoma (ACC) Or Unresectable Pheochromocytoma/Paraganglioma (PPGL) · condition mapped ALIAS · 148 trials mapped (50 active)	—	—	Adrenal Gland Pheochromocytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04394858Phase 2 · active not recruiting Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer · condition mapped CURATED_BROADER · 148 trials mapped (50 active)	—	—	Adrenal Gland Pheochromocytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02402244recruiting Project: Every Child for Younger Patients With Cancer · condition mapped ONTOLOGY_EXACT · 148 trials mapped (50 active)	—	—	Adrenal Gland Pheochromocytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03206060Phase 2 · recruiting Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma · condition mapped ALIAS · 148 trials mapped (50 active)	—	—	Adrenal Gland Pheochromocytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07784595NA · not yet recruiting Comparison of an Initial Active Follow-up and Therapeutic Care on Functional Outcome and Quality of Life in Patients With Head and Neck Paragangliomas · condition mapped ALIAS · 148 trials mapped (50 active)	—	—	Paraganglioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06427798Phase 1/Phase 2 · recruiting Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy · condition mapped ALIAS · 148 trials mapped (50 active)	—	—	Adrenal Gland Pheochromocytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06377033NA · recruiting Using the EHR to Advance Genomic Medicine Across a Diverse Health System · condition mapped ONTOLOGY_EXACT · 148 trials mapped (50 active)	—	—	Paraganglioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03015844available A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma · condition mapped ALIAS · 148 trials mapped (50 active)	—	—	Adrenal Gland Pheochromocytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07714551Phase 2 · not yet recruiting Zanzalintinib in Unresectable and Progressive MPGGs · condition mapped ALIAS · 148 trials mapped (50 active)	—	—	Adrenal Gland Pheochromocytoma	1	Observed	clinicaltrials	graph →

Autonomic Nervous System Neoplasm studied in …STUDIED_INderived10 of 148show all (up to 200)

→ studied in

NCT00004847Phase 1 · recruiting

Diagnosis of Pheochromocytoma · condition mapped ALIAS · 148 trials mapped (50 active)

—

Observed

→ studied in

NCT07743138Phase 2 · not yet recruiting

STOMP OUT: A Phase 2 Study To Evaluate The Effects Of Ivonescimab In Patients With Unresectable/Metastatic Adrenocortical Carcinoma (ACC) Or Unresectable Pheochromocytoma/Paraganglioma (PPGL) · condition mapped ALIAS · 148 trials mapped (50 active)

—

Observed

→ studied in

NCT04394858Phase 2 · active not recruiting

Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer · condition mapped CURATED_BROADER · 148 trials mapped (50 active)

—

Observed

→ studied in

NCT02402244recruiting

Project: Every Child for Younger Patients With Cancer · condition mapped ONTOLOGY_EXACT · 148 trials mapped (50 active)

—

Observed

→ studied in

NCT03206060Phase 2 · recruiting

Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma · condition mapped ALIAS · 148 trials mapped (50 active)

—

Observed

→ studied in

NCT07784595NA · not yet recruiting

Comparison of an Initial Active Follow-up and Therapeutic Care on Functional Outcome and Quality of Life in Patients With Head and Neck Paragangliomas · condition mapped ALIAS · 148 trials mapped (50 active)

—

Paraganglioma

Observed

→ studied in

NCT06427798Phase 1/Phase 2 · recruiting

Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy · condition mapped ALIAS · 148 trials mapped (50 active)

—

Observed

→ studied in

NCT06377033NA · recruiting

Using the EHR to Advance Genomic Medicine Across a Diverse Health System · condition mapped ONTOLOGY_EXACT · 148 trials mapped (50 active)

—

Paraganglioma

Observed

→ studied in

NCT03015844available

A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma · condition mapped ALIAS · 148 trials mapped (50 active)

—

Observed

→ studied in

NCT07714551Phase 2 · not yet recruiting

Zanzalintinib in Unresectable and Progressive MPGGs · condition mapped ALIAS · 148 trials mapped (50 active)

—

Observed